Conservation machine learning

2 minutes ago   |   BioData Mining


Read more ...

Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment, Acquires IP From World Leader in Respiratory Disease Medicine

6 minutes ago   |   San Diego Biotechnology

Technology, expertise from UK's Mucokinetica to accelerate repurposing of generic remedy nafamostat for COVID-19 oral, inhalation therapy SAN DIEGO, Aug. 6, 2020 /PRNewswire...
Read more ...

Dicerna guides Roche-partnered hepatitis B drug past early test

32 minutes ago   |   Fierce Biotech

Dicerna guides Roche-partnered hepatitis B drug past early test ntaylor Thu, 08/06/2020 - 08:10
Read more ...

UEP: an open-source and fast classifier for predicting the impact of mutations in protein-protein complexes

1 hour ago   |   Oxford Journals

AbstractMotivationSingle protein residue mutations may reshape the binding affinity of protein-protein interactions. Therefore, predicting its effects is of great interest in...
Read more ...

FastBMD: an online tool for rapid benchmark dose-response analysis of transcriptomics data

1 hour ago   |   Oxford Journals

AbstractMotivationTranscriptomics dose-response analysis is a promising new approach method for toxicity testing. While international regulatory agencies have spent substantial...
Read more ...

PDR: a new genome assembly evaluation metric based on genetics concerns

1 hour ago   |   Oxford Journals

AbstractMotivationExisting genome assembly evaluation metrics provide only limited insight on specific aspects of genome assembly quality, and sometimes even disagree with each...
Read more ...

Sanford Burnham Prebys awarded $4.5M to discover new drugs for mental disorders

1 hour ago   |   San Diego Biotechnology

Sanford Burnham Prebys has received a $4.5 million federal grant for research that could one day lead to new treatments for a wide range of mental disorders, the institute...
Read more ...

Crown Bioscience Signals Increased Investment in Digital Transformation with Appointment of New COO

1 hour ago   |   San Diego Biotechnology

SAN DIEGO-- COO-Crown Bioscience Appoints New COO John Gu, Signalling Increased Investment in Digital Transformation...
Read more ...

Study sheds new light on vein formation in plants

2 hours ago   |   Phys

An international team of researchers including the University of Adelaide, has found plant hormones known as strigolactones suppress the transportation of auxin, the main plant...
Read more ...

Comprehensive catalogue of the molecular elements that regulate genes

2 hours ago   |   Phys

A 17-year research project has generated a detailed atlas of the genome that reveals the location of hundreds of thousands of potential regulatory regions-a resource that will...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology

GentiBio Joins Cell Therapy Chase With $20M and New Treg Technology

One of the challenges facing cell therapy developers is collecting enough cells to produce a viable treatment. It's a particularly pronounced problem for therapies employing... Read more ...

AbbVie Walks From Voyager R&D Pact Spanning Alzheimer's, Parkinson's

AbbVie Walks From Voyager R&D Pact Spanning Alzheimer's, Parkinson's

A partnership between Voyager Therapeutics and AbbVie developing gene therapies for Alzheimer's and Parkinson's has ended without a drug for either disease reaching human... Read more ...

Interpreting the Human Genome's Instruction Manual

Interpreting the Human Genome's Instruction Manual

An artistic representation of gene regulating elements, which allow cells with the same genetic code to differentiate into many different tissues and play many varied roles in... Read more ...

IgGenix Grabs $10M to Advance Antibody Treatments for Allergies

IgGenix Grabs $10M to Advance Antibody Treatments for Allergies

About six months after the FDA approved the first treatment for peanut allergy, a new biotech, IgGenix, has raised $10 million to discover antibodies that could address that... Read more ...

As Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up

As Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up

Telemedicine giant Teladoc Health is buying health technology company Livongo Health in an $18.5 billion cash and stock deal that comes as the COVID-19 pandemic drives patients... Read more ...

Kristin Persson Named Director of Berkeley Lab's Molecular Foundry

Kristin Persson Named Director of Berkeley Lab's Molecular Foundry

Kristin Persson Kristin Persson, a senior faculty scientist in the Energy Storage & Distributed Resources Division within the Energy Technologies Area at Lawrence Berkeley... Read more ...

Geothermal Brines Could Propel California's Green Economy

Geothermal Brines Could Propel California's Green Economy

Thermal mud pots at Controlled Thermal Resources' project site at the Salton Sea. Deep beneath the surface of the Salton Sea, a shallow lake in California's Imperial County... Read more ...

Still Stuck on Adhesion Issues, FDA Rejects DBV's Peanut Allergy Patch

Still Stuck on Adhesion Issues, FDA Rejects DBV's Peanut Allergy Patch

A skin patch developed by DBV Technologies to desensitize peanut allergy sufferers to the allergen over time has been rejected by the FDA, which says the French company needs... Read more ...

CymaBay PBC Drug Hits Phase 3 Goals With Signs of Side Effect Advantage

CymaBay PBC Drug Hits Phase 3 Goals With Signs of Side Effect Advantage

CymaBay Therapeutics' investigational drug seladelpar succeeded in a late-stage trial in patients with primary biliary cholangitis , producing results that suggest it could... Read more ...

PDR: a new genome assembly evaluation metric based on genetics concerns

AbstractMotivationExisting genome assembly evaluation metrics provide only limited insight on specific aspects of genome assembly quality, and sometimes even disagree with each... Read more ...